Cart
sales@molnova.com
Sodium picosulfate monohydrate
CAS No. 1307301-38-7
Sodium picosulfate monohydrate( —— )
Catalog No. M11229 CAS No. 1307301-38-7
Sodium picosulfate monohydrate inhibits absorption of water and electrolytes, and increases their secretion.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 50MG | 31 | In Stock |
|
| 100MG | 50 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSodium picosulfate monohydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSodium picosulfate monohydrate inhibits absorption of water and electrolytes, and increases their secretion.
-
DescriptionSodium picosulfate monohydrate inhibits absorption of water and electrolytes, and increases their secretion.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1307301-38-7
-
Formula Weight499.42
-
Molecular FormulaC18H15NNa2O9S2
-
Purity>98% (HPLC)
-
SolubilitySoluble in Water
-
SMILESC1=CC=NC(=C1)C(C2=CC=C(C=C2)OS(=O)(=O)[O-])C3=CC=C(C=C3)OS(=O)(=O)[O-].O.[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
cAC 253
Amylin (AMY3) antagonist (IC50 = 0.3 μM). Protects neuronal cells from Aβ(1-42)-induced cytotoxicity in vitro. Brain penetrant. Improves spatial memory and reduces Aβ plaque number and total area in a mouse Alzheimer's disease model.
-
Glucagon-like peptid...
Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor, it is a kind of pancreatic hormone synthesized by post-translational processing of proglucagon.
-
Acetalin 1, Opioid R...
Acetalin-3 (Ac-RFMWMT-NH2), a hexapeptide, is a μ opioid receptor antagonist with high affinity for μ and κ3 opioid receptor, weak affinity for κ1 receptors and no affinity for κ2 receptors.
